CLAIM #56459 · Thermo Fisher Scientific Inc (TMO) · 2024Q3 earnings call · Oct 23, 2024 · due Dec 31, 2025
“Certainly, as we get through 2025, you'll see higher levels of utilization on that capacity to support the strong growth in sterile fill/finish.”
Marc Casper · CEO
PENDING
graded after results covering Dec 31, 2025 are reported
How to check this claim
Look at: Utilization rate (or capacity usage/output) of sterile fill/finish manufacturing capacity, as described in management commentary
It came true if: Company reports/states utilization of sterile fill/finish capacity as higher in 2025 versus 2024 levels
Where: Management commentary on quarterly earnings calls (2025 quarters) and investor presentations discussing sterile fill/finish segment
Verify independently
SEC filings for TMO ↗ · Claim quote is verbatim from the 2024Q3 earnings call.